The University of Chicago Header Logo

Connection

Hiroyuki Abe to Carcinoma, Neuroendocrine

Back to Details
This is a "connection" page, showing publications Hiroyuki Abe has written about Carcinoma, Neuroendocrine.
Hiroyuki Abe
Connection Strength
0.163
Carcinoma, Neuroendocrine
  1. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology. 2021 Feb; 78(3):381-391.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.